Methodological concerns and clinical relevance: a critical appraisal of the meta-analysis on biosimilars versus originator follitropin alfa in ART

Affiliations

• ¹ Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Paris, France.
• ² Faculté de Médecine, Université Paris Cité, Paris, France.
• ³ Department of Gynecology and Obstetrics II and Reproductive Medicine (Professor Chapron), Centre Hospitalier Universitaire (CHU) Cochin, Paris, France.
• ⁴ Department of Development, Reproduction and Cancer, Institut Cochin, INSERM U1016 (Professor Batteux), Université Paris Cité, Paris, France.
• ⁵ IVI RMA Global Research Alliance, Ginemed Porto, Porto, Portugal.
• ⁶ Department of Advanced Reproductive Risk Management and High-Risk Pregnancies, ASL Bari, Bari, Italy.
• ⁷ Reproductive and IVF Unit, PTA Conversano, Conversano, BA, Italy.
• ⁸ Reproductive Medicine and Gynecology, Faculty of Medicine, University of Tirana, Tirana, Albania.
• ⁹ Department of Reproductive Medicine and Fertility Preservation, AP-HP-Université Paris-Saclay Antoine Beclère Hospital, Clamart, France.
• ¹⁰ Department of Reproductive Biology, Arnaud de Villeneuve Hospital, Centre Hospitalier Universitaire Montpellier, INSERM U1203, Montpellier, France.
• ¹¹ Reproductive Studies Center, CER Clinic, Santiago, Chile.
• ¹² Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
• ¹³ Department of Reproductive Medicine and Fertility Preservation, Hospices Civils de Lyon, INSERM U1208, SBRI, Bron, France.
• ¹⁴ Department of Reproductive Medicine and Biology, CHU Nantes, Nantes Université, INSERM UMR 1064, Nantes, France.